心搏过缓治疗设备市场－全球产业规模、份额、趋势、机会和预测（按类型、按设备、按最终用户、按地区和竞争细分，2020-2030 年）

2024 年全球心搏过缓治疗设备市场价值为 92.1 亿美元，预计到 2030 年将达到 123.8 亿美元，预测期内年复合成长率(CAGR) 为 5.03%。这种成长主要是由于心血管疾病发生率的上升和先进起搏器技术的普及。

心搏过缓的特征是心率异常缓慢，在老年族群中越来越普遍，对有效治疗方案的需求也随之增加。市场受益于无导线起搏器、MRI 相容设备和远端监控系统等技术进步，所有这些技术都是为了改善临床结果并降低併发症的风险。

电生理学和心律管理领域的持续创新进一步加速了心搏过缓治疗设备的普及。此外，支持性报销政策和微创手术技术的进步提高了治疗的可近性，促使更多患者寻求治疗。

医疗保健投资的增加以及医疗器材製造商和研究机构之间的策略合作也在市场扩张中发挥着至关重要的作用。技术进步，加上人们对早期诊断和介入的认识不断提高，正在推动进一步的需求。

人工智慧（AI）融入心臟监测系统，显着提高了心搏过缓检测的准确性，有利于及时治疗。具有更长电池寿命和更高安全性的无线心律调节器正获得更广泛的认可，最大限度地减少了重复手术的需要。远端病人监控正变得越来越普遍，可以即时追踪心臟健康状况并更迅速地调整治疗。对微创手术的偏好促进了创新心律调节器植入技术的发展，降低了传统手术通常带来的风险。

关键市场驱动因素

心血管疾病盛行率上升

主要市场挑战

认知有限和诊断不足

主要市场趋势

植入式装置的小型化与先进化

目录

第 1 章：产品概述

第二章：研究方法

第三章：执行摘要

第四章：全球心搏过缓治疗设备市场展望

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 依类型（窦性心搏过缓、窦性停搏、病态窦房结症候群、心搏过速-心搏过缓症候群、心臟传导阻滞）
  • 按设备（心律调节器{单腔心律调节器、双腔心律调节器}、除颤器）
  • 按最终使用者（医院和诊所、门诊护理中心、其他）
  • 按地区
  • 按公司分类（2024）
• 市场地图
  • 按类型
  • 按设备
  • 按最终用户
  • 按地区

第五章：亚太心搏过缓治疗设备市场展望

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 按类型
  • 按设备
  • 按最终用户
  • 按国家/地区
• 亚太地区：国家分析
  • 中国
  • 印度
  • 澳洲
  • 日本
  • 韩国

第六章：欧洲心搏过缓治疗设备市场展望

• 市场规模和预测
• 市场占有率和预测
• 欧洲：国家分析
  • 法国
  • 德国
  • 西班牙
  • 义大利
  • 英国

第七章：北美心搏过缓治疗设备市场展望

• 市场规模和预测
• 市场占有率和预测
  • 类型
• 北美：国家分析
  • 美国
  • 墨西哥
  • 加拿大

第八章：南美洲心跳过慢治疗设备市场展望

• 市场规模和预测
• 市场占有率和预测
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第九章：中东和非洲心搏过缓治疗设备市场展望

• 市场规模和预测
• 市场占有率和预测
• MEA：国家分析
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第十章：市场动态

• 驱动程式
• 挑战

第 11 章：市场趋势与发展

• 最新动态
• 产品发布
• 併购

第 12 章：全球心搏过缓治疗设备市场：SWOT 分析

第 13 章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的力量
• 顾客的力量
• 替代产品的威胁

第 14 章：竞争格局

• Abbott Laboratories
• Biotronik
• Nihon Kohden Corporation
• Lepu Medical Technology (Beijing)Co Ltd.
• Medico SRL
• Oscor Inc
• Osypka Medical Inc.
• Microport Scientific Corporation
• Boston Scientific Corporation
• Medtronic Plc.

第 15 章：策略建议

第16章调查会社について・免责事项

Global Bradycardia Treatment Devices Market devices was valued at USD 9.21 billion in 2024 and is projected to reach USD 12.38 billion by 2030, expanding at a compound annual growth rate (CAGR) of 5.03% during the forecast period. This growth is primarily driven by the increasing incidence of cardiovascular diseases and the rising adoption of advanced pacemaker technologies.

Bradycardia, characterized by an unusually slow heart rate, is increasingly prevalent among the aging population, contributing to a heightened demand for effective treatment solutions. The market is benefiting from technological advancements such as leadless pacemakers, MRI-compatible devices, and remote monitoring systems, all of which are designed to improve clinical outcomes and reduce the risk of complications.

Ongoing innovations in electrophysiology and cardiac rhythm management have further accelerated the adoption of bradycardia treatment devices. Additionally, supportive reimbursement policies and progress in minimally invasive surgical techniques have enhanced accessibility, prompting a greater number of patients to pursue treatment.

Increased healthcare investments and strategic collaborations between medical device manufacturers and research institutions are also playing a vital role in market expansion. Technological advancements, coupled with rising awareness about early diagnosis and intervention, are driving further demand.

The integration of artificial intelligence (AI) into cardiac monitoring systems has significantly enhanced the accuracy of bradycardia detection, facilitating timely treatment. Wireless pacemakers featuring extended battery life and enhanced safety profiles are gaining wider acceptance, minimizing the need for repeated surgical procedures. Remote patient monitoring is becoming increasingly prevalent, enabling real-time tracking of cardiac health and more responsive treatment adjustments. The preference for minimally invasive procedures has fostered the development of innovative pacemaker implantation techniques, reducing the risks typically associated with conventional surgeries.

Key Market Drivers

Rising Prevalence of Cardiovascular Diseases

The increasing global burden of cardiovascular diseases (CVDs) is a major factor propelling growth in the bradycardia treatment devices market. According to the World Health Organization (WHO), CVDs are the leading cause of death worldwide, accounting for approximately 17.9 million fatalities annually. This includes conditions such as heart failure, coronary artery disease, and arrhythmias, with bradycardia being a common manifestation.

The aging global population and increasingly sedentary lifestyles are contributing to a higher incidence of CVDs, expanding the potential patient base for bradycardia treatments. Enhanced diagnostic capabilities and growing awareness of heart-related conditions have empowered healthcare providers to detect and monitor bradycardia more effectively, leading to earlier interventions and greater demand for treatment devices.

Government initiatives and public health strategies aimed at combating cardiovascular diseases are further supporting the adoption of bradycardia treatment technologies. For instance, in Europe, 82% of CVD-related deaths in 2019 were attributed to heart attacks and strokes, highlighting the urgency for preventive care and timely intervention-areas where bradycardia treatment devices play a critical role.

Key Market Challenges

Limited Awareness and Underdiagnosis

A significant barrier to market growth is the limited awareness and underdiagnosis of bradycardia. Despite its potential health implications, the condition often goes unnoticed or is misdiagnosed due to its subtle or intermittent symptoms.

Many individuals with mild bradycardia may not exhibit noticeable signs such as dizziness, fatigue, or fainting, leading them to forgo medical consultation. This contributes to a large number of undiagnosed cases and delays in treatment. Additionally, some healthcare professionals may overlook the more nuanced symptoms of bradycardia, particularly when they occur sporadically, further contributing to underdiagnosis.

Early detection is essential for effective management and the prevention of complications. However, the lack of awareness-both among the general public and within the medical community-remains a critical challenge to the timely identification and treatment of the condition.

Key Market Trends

Miniaturization and Advancement of Implantable Devices

The miniaturization of devices and innovations in implantable technologies are transforming the bradycardia treatment landscape. These trends are central to the advancement of cardiac rhythm management and have significantly enhanced patient outcomes.

Modern pacemakers and implantable cardioverter-defibrillators (ICDs) are now substantially smaller and less obtrusive, making them easier to implant and more comfortable for patients. This reduction in device size contributes to less invasive procedures, faster recovery times, and decreased surgical risk-particularly beneficial for elderly patients or those with higher surgical risks.

Miniaturized devices have also expanded the range of patients eligible for implantation, including those with smaller anatomical structures. Implantable devices now feature advanced functionalities such as adaptive pacing algorithms and remote monitoring capabilities. These features enable healthcare providers to monitor patients' cardiac rhythms in real-time, allowing for timely adjustments and more personalized treatment plans.

Key Market Players

• Abbott Laboratories
• Biotronik
• Nihon Kohden Corporation
• Lepu Medical Technology (Beijing)Co Ltd.
• Medico S.R.L.
• Oscor Inc
• Osypka Medical Inc.
• Microport Scientific Corporation
• Boston Scientific Corporation
• Medtronic Plc

Report Scope:

In this report, the Global Bradycardia Treatment Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Bradycardia Treatment Devices Market, By Type:

• Sinus Bradycardia
• Sinus Pause
• Sick Sinus Syndrome
• Tachy-brady Syndrome
• Heart Block

Bradycardia Treatment Devices Market, By Devices:

• Pacemakers
• Defibrillator

Bradycardia Treatment Devices Market, By End User:

• Hospitals & Clinics
• Ambulatory Care Centers
• Others

Bradycardia Treatment Devices Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Bradycardia Treatment Devices Market.

Available Customizations:

Global Bradycardia Treatment Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Global Bradycardia Treatment Devices Market Outlook

• 4.1. Market Size & Forecast
  • 4.1.1. By Value
• 4.2. Market Share & Forecast
  • 4.2.1. By Type (Sinus Bradycardia, Sinus Pause, Sick Sinus Syndrome, Tachy-brady Syndrome, Heart Block)
  • 4.2.2. By Devices (Pacemakers{Single Chamber Pacemaker, Dual Chamber Pacemaker}, Defibrillator)
  • 4.2.3. By End User (Hospitals & Clinics, Ambulatory Care Centers, Others)
  • 4.2.4. By Region
  • 4.2.5. By Company (2024)
• 4.3. Market Map
  • 4.3.1. By Type
  • 4.3.2. By Devices
  • 4.3.3. By End User
  • 4.3.4. By Region

5. Asia Pacific Bradycardia Treatment Devices Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type
  • 5.2.2. By Devices
  • 5.2.3. By End User
  • 5.2.4. By Country
• 5.3. Asia Pacific: Country Analysis
  • 5.3.1. China Bradycardia Treatment Devices Market Outlook
    • 5.3.1.1. Market Size & Forecast
      • 5.3.1.1.1. By Value
    • 5.3.1.2. Market Share & Forecast
      • 5.3.1.2.1. By Type
      • 5.3.1.2.2. By Devices
      • 5.3.1.2.3. By End User
  • 5.3.2. India Bradycardia Treatment Devices Market Outlook
    • 5.3.2.1. Market Size & Forecast
      • 5.3.2.1.1. By Value
    • 5.3.2.2. Market Share & Forecast
      • 5.3.2.2.1. By Type
      • 5.3.2.2.2. By Devices
      • 5.3.2.2.3. By End User
  • 5.3.3. Australia Bradycardia Treatment Devices Market Outlook
    • 5.3.3.1. Market Size & Forecast
      • 5.3.3.1.1. By Value
    • 5.3.3.2. Market Share & Forecast
      • 5.3.3.2.1. By Type
      • 5.3.3.2.2. By Devices
      • 5.3.3.2.3. By End User
  • 5.3.4. Japan Bradycardia Treatment Devices Market Outlook
    • 5.3.4.1. Market Size & Forecast
      • 5.3.4.1.1. By Value
    • 5.3.4.2. Market Share & Forecast
      • 5.3.4.2.1. By Type
      • 5.3.4.2.2. By Devices
      • 5.3.4.2.3. By End User
  • 5.3.5. South Korea Bradycardia Treatment Devices Market Outlook
    • 5.3.5.1. Market Size & Forecast
      • 5.3.5.1.1. By Value
    • 5.3.5.2. Market Share & Forecast
      • 5.3.5.2.1. By Type
      • 5.3.5.2.2. By Devices
      • 5.3.5.2.3. By End User

6. Europe Bradycardia Treatment Devices Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Devices
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. Europe: Country Analysis
  • 6.3.1. France Bradycardia Treatment Devices Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Devices
      • 6.3.1.2.3. By End User
  • 6.3.2. Germany Bradycardia Treatment Devices Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Devices
      • 6.3.2.2.3. By End User
  • 6.3.3. Spain Bradycardia Treatment Devices Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Devices
      • 6.3.3.2.3. By End User
  • 6.3.4. Italy Bradycardia Treatment Devices Market Outlook
    • 6.3.4.1. Market Size & Forecast
      • 6.3.4.1.1. By Value
    • 6.3.4.2. Market Share & Forecast
      • 6.3.4.2.1. By Type
      • 6.3.4.2.2. By Devices
      • 6.3.4.2.3. By End User
  • 6.3.5. United Kingdom Bradycardia Treatment Devices Market Outlook
    • 6.3.5.1. Market Size & Forecast
      • 6.3.5.1.1. By Value
    • 6.3.5.2. Market Share & Forecast
      • 6.3.5.2.1. By Type
      • 6.3.5.2.2. By Devices
      • 6.3.5.2.3. By End User

7. North America Bradycardia Treatment Devices Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Drug Type
  • 7.2.2. Type
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. North America: Country Analysis
  • 7.3.1. United States Bradycardia Treatment Devices Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Devices
      • 7.3.1.2.3. By End User
  • 7.3.2. Mexico Bradycardia Treatment Devices Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Devices
      • 7.3.2.2.3. By End User
  • 7.3.3. Canada Bradycardia Treatment Devices Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Devices
      • 7.3.3.2.3. By End User

8. South America Bradycardia Treatment Devices Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Devices
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. South America: Country Analysis
  • 8.3.1. Brazil Bradycardia Treatment Devices Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Devices
      • 8.3.1.2.3. By End User
  • 8.3.2. Argentina Bradycardia Treatment Devices Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Devices
      • 8.3.2.2.3. By End User
  • 8.3.3. Colombia Bradycardia Treatment Devices Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Devices
      • 8.3.3.2.3. By End User

9. Middle East and Africa Bradycardia Treatment Devices Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Devices
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. MEA: Country Analysis
  • 9.3.1. South Africa Bradycardia Treatment Devices Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Devices
      • 9.3.1.2.3. By End User
  • 9.3.2. Saudi Arabia Bradycardia Treatment Devices Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Devices
      • 9.3.2.2.3. By End User
  • 9.3.3. UAE Bradycardia Treatment Devices Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Devices
      • 9.3.3.2.3. By End User

10. Market Dynamics

• 10.1. Drivers
• 10.2. Challenges

11. Market Trends & Developments

• 11.1. Recent Developments
• 11.2. Product Launches
• 11.3. Mergers & Acquisitions

12. Global Bradycardia Treatment Devices Market: SWOT Analysis

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Product

14. Competitive Landscape

• 14.1. Abbott Laboratories
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Current Capacity Analysis
  • 14.1.5. Financials (In case of listed)
  • 14.1.6. Recent Developments
  • 14.1.7. SWOT Analysis
• 14.2. Biotronik
• 14.3. Nihon Kohden Corporation
• 14.4. Lepu Medical Technology (Beijing)Co Ltd.
• 14.5. Medico S.R.L.
• 14.6. Oscor Inc
• 14.7. Osypka Medical Inc.
• 14.8. Microport Scientific Corporation
• 14.9. Boston Scientific Corporation
• 14.10.Medtronic Plc.

15. Strategic Recommendations

16. About Us & Disclaimer